Rob Kniaz

Who they are

Rob Kniaz is a Partner at Hoxton Ventures — co-founded the firm in 2013 with Hussein Kanji and separately co-founded H Tree Capital, a deep biotech VC, in 2023.

Person

Rob studied Computer Science at the University of Maryland, then took an MS in Management Science & Engineering at Stanford — a classic engineer-to-operator pipeline. From there he moved into big tech: a technical role at Intel, then Product Manager for AdSense at Google, where he was in the room as programmatic advertising scaled globally. A stint at Fidelity rounded out his financial-services literacy before he made the jump to fund management. In 2013 he co-founded Hoxton Ventures with Hussein Kanji, bringing a Silicon Valley operator's eye to European early-stage investing — a bet that proved out through Deliveroo, Darktrace, and Preply. In 2023 he co-founded H Tree Capital with Vanela Bushi, a deep biotech and computational biology fund launched that April, signalling a deliberate move into life sciences alongside his continued Hoxton work. He contributes to Forbes on VC topics and has appeared on BBC Radio and CNBC to comment on UK venture capital and European tech. The through-line is operator-to-investor, with an expanding aperture from consumer internet to biotech.

Company

The freshest signal from Hoxton is May 2026: portfolio company Avantia, an AI-native legal-tech firm, was acquired by Carta, which runs an ERP platform for private capital management used by over 50,000 companies and investors — Hoxton called it a validation of its thesis that AI would rebuild legacy industries. A month earlier, in March 2026, Hoxton participated in the $10M Series B round of Giraffe360. Those moves follow a September 2025 team build-out in which Partner Payton Dobbs relocated from London to San Francisco and Rishabh Kaul joined as Venture Partner to advise portfolio companies on growth strategies. Hoxton has raised over $360 million across three funds and typically leads pre-seed and seed rounds with checks between $500K and $5M, taking 10–20% ownership stakes.

Market

Hoxton operates in the European early-stage venture capital market, competing and co-investing alongside firms like Octopus Ventures, with a portfolio of about 90 companies and a cumulative portfolio valuation exceeding $7 billion. Its brand is built on backing category-defining companies — Deliveroo, Darktrace, Babylon, Preply — before they were obvious bets, with an anti-thematic, pro-founder stance. Geopolitical and regulatory headwinds, including increased cross-border deal scrutiny and shifting trade frameworks in 2026, are adding complexity to the transatlantic expansion strategies that Hoxton actively helps portfolio companies pursue.

Network

Rob's closest named collaborator is Hussein Kanji, his co-founder at Hoxton Ventures since 2013. At H Tree Capital he co-founded the firm with Vanela Bushi, described as a healthcare expert. On the Hoxton team, Payton Dobbs (now San Francisco-based, formerly at Google and Nest for over 20 years) and Venture Partner Rishabh Kaul (formerly leadership at Appsmith) are the most recent additions to the orbit.

Hussein Kanji· Co-founder, Hoxton Ventures
Vanela Bushi· Co-founder, H Tree Capital; healthcare expert
Payton Dobbs· Partner, Hoxton Ventures (San Francisco)
Rishabh Kaul· Venture Partner, Hoxton Ventures

How they likely show up

Long tenure at Hoxton Ventures (co-founded 2013, still active in 2026) → thinks in fund cycles and decade-long relationship arcs, not deal-by-deal.
Product Manager at Google AdSense before becoming an investor → likely stress-tests portfolio companies on product-market fit and distribution mechanics, not just market size.
Co-founded H Tree Capital in 2023 alongside an active Hoxton role → high capacity for parallel tracks; doesn't wait for one chapter to close before starting the next.
Public voice spans Forbes writing, BBC Radio, and CNBC commentary → comfortable translating complex VC dynamics for general audiences; expects a certain level of intellectual directness in conversation.
Amateur coding on internal data science tools as a personal interest → retains a builder's instinct; likely engages more deeply when technical specifics are on the table.
Aiming to visit 100 countries as a personal goal → suggests an internationalist mindset that probably shapes how he thinks about portfolio company expansion beyond the UK.

Conversation tips

→ Come with a specific view on a sector or deal dynamic — he writes and speaks publicly on VC, so vague takes will fall flat; engage him at the thesis level.
→ His Google AdSense background means he thinks carefully about business model design and distribution; tie any company discussion to how the model actually scales.
→ Ask about H Tree Capital separately from Hoxton — the biotech fund is a distinct strategic bet and he'll have distinct views on where deep tech life sciences is heading.
→ Reference a named portfolio company (Avantia's Carta exit, Darktrace, Deliveroo) rather than speaking abstractly about 'your portfolio' — specificity signals you've done the work.
→ The 100-countries goal is a genuine signal about how he thinks; if international expansion or cross-border dynamics come up, he'll have opinions shaped by lived experience, not just market maps.

Toolbox

Openers

Open on the Avantia acquisition by Carta in May 2026 — it's the most recent exit from the portfolio and he's on record calling it a validation of Hoxton's AI-rebuilding-legacy-industries thesis; asking what it confirms (or complicates) about that thesis is a direct, non-generic opener.
He co-founded H Tree Capital with Vanela Bushi in April 2023 as a dedicated deep biotech fund — a deliberate second platform alongside Hoxton — worth opening on because it signals where he's placing personal conviction beyond the main fund.
He built his pre-VC career as PM for AdSense at Google, which means he shaped one of the internet's most important ad products before ever writing a check; referencing that product background and how it informs how he evaluates founders is a specific, textured entry point.

Discovery questions

Hoxton's anti-thematic approach has backed non-obvious categories like AI-driven cybersecurity and food delivery early — how do you distinguish a genuinely nascent category from a market that just doesn't exist?
You co-founded H Tree Capital in 2023 specifically for deep biotech — what gap in the European funding landscape prompted a separate vehicle rather than expanding Hoxton's mandate?
Payton Dobbs relocated to San Francisco in 2025 and Hoxton is actively supporting US expansion for portfolio companies — how has the firm's transatlantic model changed now that geopolitical and regulatory friction is rising on cross-border deals?

Avoid

Don't lead with generic questions about what stage or sector Hoxton focuses on — he's written publicly on this and the anti-thematic, pro-founder stance is well documented; it signals you haven't done basic prep.

Make it yours